secwatch.observer — SEC 8-K summary
======================================

Issuer:     Skye Bioscience, Inc. (SKYE)
CIK:        0001516551
Form:       8-K/A
Filed at:   2026-04-06T23:59:59+00:00
Accession:  0001628280-26-023903
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Skye Bioscience amends 8-K to correct option repricing share count to 2,458,158
-------------------------------------------------------------------------------

- Amendment corrects a scrivener's error: total shares underlying Repriced Options is 2,458,158.
- No other changes to the original April 3, 2026 8-K filing on compensatory arrangements.
- CEO Punit Dhillon signed the amendment dated April 6, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1516551/000162828026023903/0001628280-26-023903-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1516551/000162828026023903/skye-20260331.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-023903

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer